Medication info
Rozduo Tablet 10/20 Milligrams

Rozduo Tablet 10/20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium Micronized›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Pink egg-shaped film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTPX3)], 30 tablets/bottle
Approval status
Active

MFDS item code 201506796 · Approved 2015.09.24 · Insurance code 645404540

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used to lower total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia, especially those with heterozygous familial and non-familial hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol levels. It is prescribed as an adjunct to a proper diet to limit saturated fat and cholesterol intake, particularly in cases where dietary management alone is insufficient. Additionally, it is administered to patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia to help improve cardiovascular disease risk. Before use, it is necessary to identify secondary factors causing dyslipidemia and to treat them if necessary. This medication effectively improves the patient's lipid profile and enhances cardiovascular health.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This medication can rarely cause serious side effects such as rhabdomyolysis, which may result in muscle abnormalities; therefore, patients should immediately inform a physician if they experience sudden muscle pain or weakness. This medication may affect liver function; hence, it should not be used in patients with liver disease or those with abnormally elevated liver enzyme levels. Patients with muscle diseases or at high risk for adverse muscle reactions, such as those with severe infections, hypotension, or after major surgery or trauma, must be carefully monitored when using this medication, and discontinuation may be necessary. This medication should not be administered to individuals with certain genetic conditions or lactose intolerance. Pregnant women, women who may become pregnant, and nursing mothers should not use this medication, and women of childbearing potential should use appropriate contraception during treatment. This medication may interact with other drugs, so it is essential to consult a physician, especially if taking medications that affect drug metabolism in the liver. Elderly patients or those with impaired renal function are also at higher risk for adverse muscle reactions and should be monitored closely. Regular liver function and muscle enzyme tests should be performed during treatment to detect any abnormalities early. Caution is needed when driving or operating machinery due to the possibility of dizziness.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, increased ALT, edema, myalgia, increased AST, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function tests, increased serum lactate dehydrogenase, pruritus, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, myositis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, increased CK levels, muscle cramps, gout, erectile dysfunction, chest pain, chest discomfort, generalized edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue diseases, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, increased serum creatinine, elevated blood pressure, increased serum urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from exposure to air or moisture. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink egg-shaped film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTPX3)], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.